Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Weinstein

Showing results (1011-1020 of 1,016) with videos related to

Pageof 102
Sort By:
You have reached the last page of results.This site can display upto 1,016 results.
Oral Oncology|July 18, 2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311Robert L Ferris, Yael Flamand, F Christopher Holsinger, et al.
Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Pageof 102

Showing results (1011-1020 of 1,016) with videos related to

Sort By:
Pageof 102
You have reached the last page of results.This site can display upto 1,016 results.
Oral Oncology|July 18, 2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311Robert L Ferris, Yael Flamand, F Christopher Holsinger, et al.
Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Pageof 102